{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:16:32Z","timestamp":1775682992683,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12874-019-0781-1","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:14:22Z","timestamp":1562681662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sequence symmetry analysis graphic adjustment for prescribing trends"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-0941","authenticated-orcid":false,"given":"Adrian Kym","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Ellen","family":"Roughead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Leanne","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"issue":"5","key":"781_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pds.3417","volume":"22","author":"IA Wahab","year":"2013","unstructured":"Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22(5):496\u2013502. \n                    https:\/\/doi.org\/10.1002\/pds.3417\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"781_CR2","doi-asserted-by":"publisher","unstructured":"Wahab IA, Pratt NL, Kalisch LM, and Roughead EE. \u201cSequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal?\u201d Adv Pharmacoepidemiol Drug Saf 2013; 2:4. \n                    https:\/\/doi.org\/10.4172\/2167-1052.1000140\n                    \n                  . Accessed 15 Jun 2017.","DOI":"10.4172\/2167-1052.1000140"},{"key":"781_CR3","doi-asserted-by":"crossref","unstructured":"Pratt NL, Ilomaki J, Raymond C, Roughead EE. The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study. BMC Med Res Methodol. 2014;14(66). \n                    http:\/\/www.biomedcentral.com\/1471-2288\/14\/66\n                    \n                  .","DOI":"10.1186\/1471-2288-14-66"},{"issue":"5","key":"781_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","volume":"7","author":"J Hallas","year":"1996","unstructured":"Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7(5):478\u201384.","journal-title":"Epidemiology"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/1099-1557(200011)9:6<491::AID-PDS532>3.0.CO;2-O","volume":"9","author":"KA Colebatch","year":"2000","unstructured":"Colebatch KA, Marley J, Doecke CJ, Miles HB, Gilbert A. Evaluation of a patient event report monitoring system. Pharmacoepidemiol Drug Saf. 2000;9:491\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"781_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/pds.1063","volume":"14","author":"J Hallas","year":"2005","unstructured":"Hallas J. Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf. 2005;14(7):455\u201363. \n                    https:\/\/doi.org\/10.1002\/pds.1063\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"781_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds","volume":"18","author":"I Tsiropoulos","year":"2009","unstructured":"Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18(6):483\u201391. \n                    https:\/\/doi.org\/10.1002\/pds\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"781_CR8","unstructured":"Department of Health. \u201cSources of epidemiological data for use in generating utilisation estimates 2015. Canberra: Commonwealth of Australia.\u201d Accessed 25 Nov 2015."},{"issue":"4","key":"781_CR9","doi-asserted-by":"publisher","first-page":"e2541546","DOI":"10.17061\/phrp2541546","volume":"25","author":"E Paige","year":"2015","unstructured":"Paige E, Kemp-Casey A, Korda R, Banks E. Using Australian pharmaceutical benefits scheme data for pharmacoepidemiological research: challenges and approaches. Public Health Res Pract. 2015;25(4):e2541546. \n                    https:\/\/doi.org\/10.17061\/phrp2541546\n                    \n                  .","journal-title":"Public Health Res Pract"},{"issue":"9","key":"781_CR10","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/pds.3440","volume":"22","author":"N Pratt","year":"2013","unstructured":"Pratt N, Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Kimura M, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf. 2013;22(9):915\u201324. \n                    https:\/\/doi.org\/10.1002\/pds.3440\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/joim.12186","volume":"275","author":"J Hallas","year":"2014","unstructured":"Hallas J, Potteg\u00e5rd A. Use of self-controlled designs in pharmacoepidemiology. J Intern Med. 2014;275:581\u20139. \n                    https:\/\/doi.org\/10.1111\/joim.12186\n                    \n                  .","journal-title":"J Intern Med"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF02162161","volume":"10","author":"CH Reinsch","year":"1967","unstructured":"Reinsch CH. Smoothing by spline functions. Numer Math. 1967;10:177\u201383.","journal-title":"Numer Math"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-019-0781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12874-019-0781-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-019-0781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:13:00Z","timestamp":1594163580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-019-0781-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1186\/s12874-019-0781-1","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"14 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was approved by the Australian Government Department of Human Services External Requests Evaluation Committee\u2014Request approval number MI5157. Since the research was undertaken on existing medicines data with no personal identifiers, ethics approval was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}